Clinical Trial Update: Treatment of Chronic Wounds in Diabetic Foot Syndrome With Allogeneic Adipose Derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 trial evaluating allogeneic adipose-derived mesenchymal stem cells for treating diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Allogeneic adipose-derived mesenchymal stem cells (allogeneic adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: COMPLETED